CAR-T Therapy in HIV: Pioneering Advances and Navigating Challenges
Abstract. Chimeric antigen receptor T (CAR-T) cell therapy, renowned for its successes in cancer treatment, is now entering the field of human immunodeficiency virus (HIV) therapy, presenting both opportunities and challenges. With the emergence of broadly neutralizing antibodies, multi-target CARs,...
Saved in:
| Main Authors: | Xiao Wang, Jianyang Liu, Feike Hao, Tatchapon Ajavavarakula, Xuanling Shi, Haijuan Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Health - Lippincott Williams Wilkins
2024-10-01
|
| Series: | Infectious Diseases & Immunity |
| Online Access: | http://journals.lww.com/10.1097/ID9.0000000000000129 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CAR-T therapy: pioneering a new era in the treatment of autoimmune diseases
by: Yuanhao Wu, et al.
Published: (2025-08-01) -
IoMT landscape: navigating current challenges and pioneering future research trends
by: Badraddin Alturki, et al.
Published: (2024-12-01) -
Current Advances and Challenges in CAR-T Therapy for Hematological and Solid Tumors
by: Zhang G, et al.
Published: (2025-06-01) -
Tandem CAR-T cell therapy: recent advances and current challenges
by: Sara Gómez-Melero, et al.
Published: (2025-02-01) -
Advances and challenges in CAR-T cell therapy for head and neck squamous cell carcinoma
by: Sahand Saeidpour Masouleh, et al.
Published: (2025-05-01)